The Vertical Group

Portfolio · 1

Galil Medical

Cryotherapy for Cancer Treatment

1 round $52.0M committed Latest: 2006-12

Investment activity

1 portfolio exit on record.

Q&A

What is The Vertical Group's primary investment focus by sector?

The Vertical Group primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.

Can you describe a notable exit for The Vertical Group?

The Vertical Group had a notable exit in May 2016 with the acquisition of Galil Medical by BTG plc for $110M. Galil Medical, founded in 1997, specializes in cryotherapy for cancer treatment.

What is the most recent investment activity for The Vertical Group?

The Vertical Group's most recent recorded investment activity was in December 2006, when it invested in Galil Medical.

Which company is a key part of The Vertical Group's portfolio?

A key company in The Vertical Group's portfolio is Galil Medical, which focuses on cryotherapy for cancer treatment.